Billiontoone Inc Revenue Growth Rates (BLLN), Current and Historic Growth - CSIMarket
CSIMarket
 


Billiontoone Inc   (NASDAQ: BLLN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

BLLN's Revenue Growth by Quarter and Year

Billiontoone Inc 's Revenue results by quarter and year




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BLLN/growth
https://api.csimarket.com/api/v1/companies/BLLN/fundamentals
https://api.csimarket.com/api/v1/companies/BLLN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
BLLN Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 122.98
2nd Quarter June 109.45
1st Quarter March 108.10
FY 340.53





BLLN Revenue third quarter 2026 Y/Y Growth Comment
Billiontoone Inc reported Revenue rise of 47.42% year on year in the third quarter 2026, to $ 122.98 millions, this is lower than Billiontoone Inc 's recent average Revenue rise of 88.28%.

Looking into third quarter 2026 results within Medical Laboratories industry 2 other companies have achieved higher Revenue growth. While Billiontoone Inc ' s Revenue jump of 47.42% ranks overall at the positon no. 383 in the third quarter 2026.




BLLN Revenue ( Y/Y Growth %) 2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 47.42 %
2nd Quarter June 64.41 %
1st Quarter March 83.34 %
FY   -

Financial Statements
Billiontoone Inc 's third quarter 2026 Revenue $ 122.98 millions BLLN's Income Statement
Billiontoone Inc 's third quarter 2025 Revenue $ 83.42 millions Quarterly BLLN's Income Statement


BLLN Revenue (Quarter on Quarter Growth %)

2026
FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 12.36 %
2nd Quarter June 1.25 %
1st Quarter March 12.55 %
FY (Year on Year)   -




Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #101
Overall #383

Revenue Y/Y Growth Statistics
High Average Low
117.12 % 88.28 % 64.4 %
(Dec 31 2025)   (Mar 31 2026)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #3
Healthcare Sector #101
Overall #383
Revenue Y/Y Growth Statistics
High Average Low
117.12 % 88.28 % 64.4 %
(Dec 31 2025)   (Mar 31 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Billiontoone Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
25.3 % 13.25 % 1.25 %
(Sep 30 2025)  


BLLN's III. Quarter Q/Q Revenue Comment
Billiontoone Inc achieved in the III. Quarter 2026 below company average Revenue rise of 12.36% quarter on quarter, to $ 122.98 millions.

Within Medical Laboratories industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Billiontoone Inc 's Revenue growth quarter on quarter, overall rank is 736.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #8
Healthcare Sector #122
Overall #736
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #8
Healthcare Sector #122
Overall #736
Revenue Q/Q Growth Statistics
High Average Low
25.3 % 13.25 % 1.25 %
(Sep 30 2025)  


BLLN's III. Quarter Q/Q Revenue Comment
Billiontoone Inc achieved in the III. Quarter 2026 below company average Revenue rise of 12.36% quarter on quarter, to $ 122.98 millions.

Within Medical Laboratories industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Billiontoone Inc 's Revenue growth quarter on quarter, overall rank is 736.


Billiontoone Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)
12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.00
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking #
Seqeuential Revenue Change (TTM) -
Seq. Revenue Growth (TTM) Overall Ranking #


Cumulative Revenue growth Comment
In the Mar 31 2026 period, Billiontoone Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Billiontoone Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2026 period, Billiontoone Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Billiontoone Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BLLN's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Vivosim Labs Inc 82.14%$ 82.143 millions
Syndax Pharmaceuticals Inc 81.59%$ 81.592 millions
Iovance Biotherapeutics inc 80.07%$ 80.074 millions
Rhythm Pharmaceuticals Inc 79.59%$ 79.594 millions
Omniab Inc 78.34%$ 78.339 millions
Aclarion Inc 78.09%$ 78.086 millions
Personalis Inc 76.59%$ 76.585 millions
Delcath Systems Inc 76.05%$ 76.047 millions
Mobia Medical Inc 73.28%$ 73.280 millions
Wave Life Sciences Ltd 72.95%$ 72.950 millions
Igc Pharma Inc 71.73%$ 71.728 millions
Phathom Pharmaceuticals Inc 71.14%$ 71.142 millions
Ptc Therapeutics inc 69.57%$ 69.571 millions
Seres Therapeutics Inc 68.95%$ 68.946 millions
Alamar Biosciences Inc 68.46%$ 68.458 millions
Carlsmed Inc 66.74%$ 66.736 millions
Corcept Therapeutics Inc63.97%$ 63.974 millions
Tarsus Pharmaceuticals Inc 63.92%$ 63.921 millions
Tg Therapeutics Inc 60.74%$ 60.743 millions
Heartflow Inc 60.42%$ 60.425 millions
Glaukos Corp59.02%$ 59.021 millions
X4 Pharmaceuticals Inc58.64%$ 58.640 millions
Kiniksa Pharmaceuticals International Plc58.12%$ 58.121 millions
Envoy Medical Inc 57.14%$ 57.143 millions
Humacyte Inc 55.21%$ 55.208 millions
Butterfly Network Inc 53.45%$ 53.453 millions
Avita Medical Inc 53.05%$ 53.054 millions
Immunitybio inc 52.34%$ 52.338 millions
Axsome Therapeutics Inc 51.87%$ 51.873 millions
Innovative Eyewear Inc 51.12%$ 51.123 millions


About Billiontoone Inc Revenue Growth Rates (BLLN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Billiontoone Inc (CIK 2070849).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0002070849-26-000082
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Billiontoone Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.